RecallRadar

FDA Drug recall D-0926-2018

Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for:…

On 2018-05-23 the FDA classified a Class I recall of Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for:… by Auromedics Pharma, citing presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0926-2018
ClassificationClass I
Statusterminated
Initiated2018-05-01
Published2018-05-23
Last updated2026-09-13 11:52 UTC
CompanyAuromedics Pharma
DistributionUS

Product

Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30

Reason

Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass

Identifiers

ndc55150-119-30
ndc55150-120-30
ndc55150-121-50
code_infoLot #s: PP0317061-A, PP0317049-A; EXP August 2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0926-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.